ExpreS2ion and Intravacc enter collaboration agreement
(WorldNews Denmark)

Hørsholm, Denmark / Bilthoven, the Netherlands, December 11, 2017 - Today, ExpreS2ion Biotechnologies ApS (`ExpreS2ion`) and Intravacc (the Institute for Translational Vaccinology), announce the signing of a collaboration agreement. This agreement strengthens ExpreS2ion`s ability to service customers and partners across the full value chain of vaccine development and expands the commercial opportunities for both organisations. Under the agreement, Intravacc will serve as a preferred GMP (Good Manufacturing Practice) partner for ExpreS2ion. The agreement contains no financial exchange between ExpreS2ion and Intravacc. However, it expands the commercial opportunities in the vaccine field for...